TITLE

The aspirin question

PUB. DATE
June 2013
SOURCE
Consumer Reports on Health;Jun2013, Vol. 25 Issue 6, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the prevalence of heart attacks and strokes among U.S. consumers and discusses the role that a low dose aspirin regimen can play in preventing heart attacks and strokes. A discussion of medical complications which can be associated with aspirin, and of aspirin alternatives and add-ons which are available to prevent the complications, is presented. INSETS: Aspirin alternatives and add-ons;Resistance to aspirin?.
ACCESSION #
87761825

 

Related Articles

  • Proton Pump Inhibitors and the Prevention of Recurrent GI Bleed in Patients Treated with Clopidogrel. Oyetayo, O.O.; Farris, C.A.; Wahawisan, J. // Clinical Medicine Insights: Therapeutics;2012, Issue 4, p9 

    Clopidogrel is an antiplatelet agent indicated in the management of atherothrombotic conditions. Bleeding is a predictable adverse event associated with antiplatelet agents. While non-ulcerogenic; a major site of bleeding with clopidogrel is the gastrointestinal (GI) tract. The risk of GI...

  • ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use Abraham, Neena S; Hlatky, Mark A; Antman, Elliott M; Bhatt, Deepak L; Bjorkman, David J; Clark, Craig B; Furberg, Curt D; Johnson, David A; Kahi, Charles J; Laine, Loren; Mahaffey, Kenneth W; Quigley, Eamonn M; Scheiman, James; Sperling, Laurence S; Tomaselli, Gordon F // American Journal of Gastroenterology;Dec2010, Vol. 105 Issue 12, p2533 

    The article discusses the use of proton pump inhibitors (PPI) and thienopyridines as an alternative treatment for cardiovascular (CV) diseases. It says that clopidogrel is more effective than aspirin in reducing main CV events. It mentions the greater risk for gastrointestinal (GI) bleeding in...

  • Management of nonvariceal upper gastrointestinal bleeding. Wee, E. // Journal of Postgraduate Medicine;Apr-Jun2011, Vol. 57 Issue 2, p161 

    Nonvariceal upper gastrointestinal bleeding is unique from variceal bleeding in terms of patient characteristics, management, rebleeding rates, and prognosis, and should be managed differently. The majority of nonvariceal upper gastrointestinal bleeds will not rebleed once treated successfully....

  • Clopidogrel in ischemic heart disease: A critical appraisal. Al-Otaiby, Mohammed A.; Al-Moghairi, Abdulrahman M. // Health (1949-4998);Mar2013, Vol. 5 Issue 3, p465 

    Aspirin and clopidogrel are the commonest dual antiplatelet agents being used in the secondary prevention of cardiovascular disease. In high risk patients with coronary heart disease, the use of aspirin was associated with a significant risk reduction of myocardial infarction, stroke and...

  • Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes. Schmugge, Markus; Speer, Oliver; Kroiss, Sabine; Knirsch, Walter; Kretschmar, Oliver; Rand, Margaret; Albisetti, Manuela // European Journal of Pediatrics;Jul2015, Vol. 174 Issue 7, p933 

    Very few studies have investigated dose response of aspirin and agreement of different platelet function assays in children. One hundred five children were studied at baseline and after interventional cardiac catheterization during aspirin treatment and, in cases of aspirin resistance (AR),...

  • Advances in Our Understanding of ''Resistance'' to Antiplatelet Agents for Prevention of Ischemic Stroke. Gorelick, Philip B.; Farooq, Muhammad U. // Stroke Research & Treatment;2013, p1 

    We review the role of aspirin and clopidogrel for prevention of ischemic stroke and explore the concept of antiplatelet therapy resistance both from a laboratory and clinical perspective and genetic polymorphisms that might influence platelet reactivity with clopidogrel administration. Debates...

  • PPIs and Clopidogrel: Do We Have to Worry? Kuritzky, Louis // OB/GYN Clinical Alert;Dec2009, Vol. 26 Issue 8, p23 

    The article reports on the pharmacological relation between proton pump inhibitor (PPI) and clopidogrel in the U.S. It mentions that the antiplatelet effect of clopidogrel depends on its conversion and activation through the 2C19 pathway of the P450 system where the blockade of this pathway...

  • Low-Dose Aspirin May Be Just as Effective as High-Dose Therapy.  // Heart Advisor;Jul2012, Vol. 15 Issue 7, p10 

    The article discusses the effectiveness of low-dose aspirin in reducing the risk of heart attack and bleeding. It cites a study which found that there is no difference in high-dose versus low-dose aspirin therapy in preventing recurring cardiovascular events. Cleveland Clinic cardiologist...

  • The Aspirin test.  // Asian Pacific Post;5/29/2014, p10 

    The article focuses on a study which shows the efficacy of aspirin to help prevent heart attacks and strokes among high-risk individuals in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics